Planning · K260322
Acorn 3D Software (AC-SEG-4009); Acorn 3DP Model (AC-101-XX)
A spine-planning suite whose newest clearance concerns correction simulation while its machine-learning segmentation and PCCP come from earlier submissions.
Mighty Oak Medical
- Pathway
- Traditional 510(k)
- Decision
- Jun 11, 2026
- Product code
- QIH
- Evidence
- Nonclinical
- First published
- Sep 9, 2026
- Page updated
- Sep 17, 2026
- Evidence search
- Sep 8, 2026
- Professional review
- Not claimed
Anonymous editorial source review; independent regulatory, legal, or professional peer review is not claimed. Page updates do not reset evidence dates.
What FDA established
FDA accepted additional alignment, measurement and correction-simulation functions while retaining the previously cleared locked ML segmentation and its inherited PCCP.
What FDA did not establish
It does not prove better correction, fewer complications, autonomous planning or a newly authorized adaptive model in K260322.
Intended use
Visualize and segment medical images, align anatomy, measure spinopelvic geometry, plan pedicle screw placement, simulate correction and produce digital or physical three-dimensional models.
- Input
- CT, synthetic CT or CTA DICOM imaging; User-defined reference geometry and surgical correction inputs
- Output
- Editable vertebral and sacral segmentations; Aligned anatomy and spinopelvic measurements; Thoracic and lumbar pedicle-screw trajectories; Simulated correction plans and exportable three-dimensional models
- Use boundary
- Outputs require expert clinical judgment and user review; the software does not autonomously select or execute a surgical correction.
AI disclosure and function
AI/ML explicit
The suite retains a 3D U-Net machine-learning model for automatic vertebral and sacral segmentation; the newly added Correction module is algorithmic planning and simulation rather than a newly trained AI model.
No ML algorithm improvement or PCCP change occurred in K260322; the applicable segmentation PCCP was authorized in K234009 and carried through prior submissions.
No foundation-model, LLM, or generative-AI function was identified in the reviewed FDA materials.
Validation
Software verification, end-user validation and bench testing of the new Correction module, including simulated plans against surgeon-defined angular targets and intra- and inter-observer variability.
- Comparator
- The K252103 predicate suite and surgeon-defined correction inputs with predefined angular acceptance criteria.
- Ground truth
- Surgeon-defined target angular metrics and repeat measurements used as nonclinical reference values.
- Representation
- Not applicable to the reported bench and end-user testing for the new module; no new patient cohort was described for K260322.
Reported performance
- Target angular accuracy
- within 3 degreesBench accuracy of simulated correction against surgeon-defined inputs, not achieved postoperative alignment.
- Intra- and inter-observer variability
- less than 3 degrees by mean absolute difference and 2×SDRepeatability of simulated planning observations, not clinical-outcome consistency.
Limitations
- The new submission primarily validates correction simulation through bench and end-user testing.
- No patient-level deformity correction, reoperation or neurological-outcome evidence was reported.
- The ML segmentation evidence and PCCP originate from earlier submissions rather than a new model change in K260322.
It does not prove better correction, fewer complications, autonomous planning or a newly authorized adaptive model in K260322.
PCCP / Change control
Inherited from K234009; the indexed submission itself shows a “No” database flag. Controlled future updates to machine-learning segmentation of bony anatomy under the K234009 protocol; released algorithms remain trained, tuned and locked.
- Train, tune and lock each modified algorithm before release
- Assess changes against defined technical and performance specifications
- Mitigate degradation in segmentation performance within unchanged indications
A PCCP authorizes bounded changes under predefined controls. It is not permission for unrestricted or continuously self-learning behavior.
Postmarket check
No exact-name openFDA device-enforcement result was found in the targeted query.
No exact-name openFDA result found as of 2026-09-08; this is not proof that no recall exists.
Primary FDA sources
- FDA AI-enabled device list — Submission K260322Confirms inclusion, list display name, company, lead panel, product code and decision date only.
- FDA submission database — 510(k) K260322Confirms pathway, review panel, decision, primary and subsequent product codes, and No PCCP database flag.
- FDA decision summary — 510(k) summary pp. 1-8; performance p. 4; AI and PCCP lineage pp. 7-8Supports intended use, predicates, current module changes, bench results, ML segmentation description and inherited PCCP lineage.
Sources checked Sep 8, 2026 · Next scheduled review Oct 8, 2026. “No exact-name result” is a bounded search finding, not proof that no safety event or recall exists.